Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway

Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway

Osteoporosis is a chronic inflammatory disease that severely affects quality of life. <i>Cornus officinalis</i> is a Chinese herbal medicine with various bioactive ingredients, among which morroniside is its signature ingredient. Although anti-bone resorption drugs are the main treatment...

Full description

Bibliographic Details
Main Authors: Jirimutu Xiao, Qiuge Han, Ziceng Yu, Mengmin Liu, Jie Sun, Mao Wu, Heng Yin, Jingyue Fu, Yang Guo, Lining Wang, Yong Ma
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceuticals
Subjects:
morroniside
osteoporosis
inflammation
osteogenic differentiation
TRAF6-mediated MAPK/NF-κB signaling pathway
Online Access:https://www.mdpi.com/1424-8247/16/10/1438

Internet

https://www.mdpi.com/1424-8247/16/10/1438

Similar Items